BOSTON–(BUSINESS WIRE)–Activ Surgical, a digital surgery pioneer, today announced that it has named Manisha Shah-Bugaj as its new Chief Executive Officer. Shah-Bugaj has served as Activ Surgical’s Chief Operating Officer since January 2022, leading the Company’s impending global commercialization efforts around its first product, ActivSight Intelligent Light, which aims to provide enhanced visualization and real-time, on-demand surgical insights in the operating room. In her expanded role as CEO, Shah-Bugaj will oversee the ongoing development and commercialization of Activ Surgical products and engage with company partners, customers, and investors. Activ Surgical’s outgoing CEO, Todd Usen, will remain on the Company’s Board of Directors.
Prior to joining Activ Surgical, Shah-Bugaj architected the gynecology unit at Olympus from the ground up in the U.S., ultimately serving as General Manager and Global Vice President for the company, and played an integral role in expanding the gynecology business internationally. She has more than two decades of experience, including building and implementing corporate business plans, directing regional and global businesses aligned to financial and operational targets, hiring and establishing new teams, and managing product portfolios.
“Manisha is the perfect leader to take on the CEO position as Activ Surgical pivots from primarily a research and product development organization to commercialization of the Company’s products,” said Paul Meister, chairman, board of directors, Activ Surgical. “She has an impressive track record as a successful medtech executive and transformational operationally-focused leader with deep expertise in commercializing complex technologies and scaling businesses to meet a wide range of customer needs. I look forward to continuing our close working relationship and am excited about the possibilities for Activ Surgical with Manisha in this leadership role.”
“I am honored to follow in Todd’s footsteps and lead our extraordinarily talented team as the next CEO of Activ Surgical,” said Shah-Bugaj. “My passion for developing cutting-edge technologies that solve the biggest challenges in healthcare, coupled with my experience in commercializing and scaling new medtech products and systems, has led me to this career-defining moment. I am humbled and grateful for the opportunity to lead Activ Surgical into this new chapter of our history as we aim to usher in a new era of patient safety and surgical care in operating rooms around the world.”
For more information about Activ Surgical and its technology, please visit www.activsurgical.com.
About Activ Surgical
Activ Surgical is the pioneering digital surgery company that completed the world’s first autonomous robotic surgery of soft tissue in 2018. The company aims to transform the collective surgical experience by leveraging emerging technologies and data into insights that make world-class surgery accessible for all, and for every surgical imaging system to deliver intelligent information that reduces surgical complication rates, ushering in a new standard of patient care and safety. Activ Surgical is privately held, and backed by Cota Capital, BAM Funds, Magnetar Capital, Hikma Ventures, Mint Ventures, Castor Ventures, Dream One Vision, NVIDIA, DNS Capital, GreatPoint Ventures (GPV), Artis Ventures, Tao Capital Partners, LRVHealth, Rising Tide VC, SONY Innovation Fund and 8VC. Learn more at www.activsurgical.com.
